Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01268449
Other study ID # Laser-tinnitus-202
Secondary ID
Status Completed
Phase Phase 2
First received December 29, 2010
Last updated December 29, 2010
Start date March 2008
Est. completion date September 2010

Study information

Verified date August 2010
Source Islamic Azad University of Mashhad
Contact n/a
Is FDA regulated No
Health authority Iran: Ministry of Health
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine wether low dose laser is effective on idiopathic subjective tinnitus.


Recruitment information / eligibility

Status Completed
Enrollment 66
Est. completion date September 2010
Est. primary completion date August 2010
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Adults older than 18 years old

- Idiopathic, subjective, unilateral tinnitus with at least 2 month duration

Exclusion Criteria:

- Patients with chronic otitis media

- Patients with tympan perforation with any underlying cause

- Patients with external otitis

- Patients with tinnitus related to a retrocochlear lesion or other known lesions of the ear

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Radiation:
Low dose laser
5mv laser with a wavelength of 650nm
Placebo
The act of radiating laser to the ear is done while the set is off.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Islamic Azad University of Mashhad
See also
  Status Clinical Trial Phase
Completed NCT00955799 - Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus Phase 3
Completed NCT00739635 - Efficacy, Safety and Tolerability of Neramexane in Patients With Subjective Tinnitus Phase 3
Completed NCT03550430 - Neurofeedback for Tinnitus - Does Frequency Specificity Matter? N/A
Completed NCT00772980 - Efficacy, Safety and Tolerability of Neramexane in Comparison to Placebo in Patients With Subjective Tinnitus Phase 3
Completed NCT04829214 - OTO-313 in Subjects With Unilateral Subjective Tinnitus Phase 2
Completed NCT01177137 - Tinnitus Retraining Therapy Trial Phase 3
Terminated NCT00827008 - Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus Phase 3
Completed NCT00567892 - Collaborative Tinnitus Research at Washington University Phase 2
Unknown status NCT00555776 - Effect of Gabapentin on Idiopathic Subjective Tinnitus Phase 2
Completed NCT05265949 - The Effects of Weight Loss on Tinnitus Symptoms N/A
Completed NCT04696588 - Neck Kinesiotherapy and Massage in Tinnitus Treatment N/A